Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)

Clinical trial NCT03748550 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03748550
Sponsor: Nova Scotia Health Authority
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Cancer, Breast Cardiotoxicity Cardiovascular Diseases

Start date: 2019-04-29
Primary completion: 2025-06-30
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.